Cross Staff Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $319K | Sell |
6,888
-90
| -1% | -$4.17K | 0.24% | 99 |
|
|
2025
Q1 | $426K | Buy |
6,978
+8
| +0.1% | +$488 | 0.32% | 82 |
|
|
2024
Q4 | $394K | Sell |
6,970
-193
| -3% | -$10.9K | 0.27% | 88 |
|
|
2024
Q3 | $371K | Buy |
7,163
+8
| +0.1% | +$414 | 0.29% | 91 |
|
|
2024
Q2 | $297K | Buy |
7,155
+9
| +0.1% | +$374 | 0.25% | 95 |
|
|
2024
Q1 | $388K | Buy |
7,146
+8
| +0.1% | +$434 | 0.33% | 86 |
|
|
2023
Q4 | $366K | Buy |
7,138
+7
| +0.1% | +$359 | 0.32% | 86 |
|
|
2023
Q3 | $414K | Buy |
7,131
+6
| +0.1% | +$348 | 0.4% | 71 |
|
|
2023
Q2 | $456K | Buy |
7,125
+5
| +0.1% | +$320 | 0.42% | 70 |
|
|
2023
Q1 | $493K | Sell |
7,120
-45
| -0.6% | -$3.12K | 0.49% | 63 |
|
|
2022
Q4 | $516K | Buy |
7,165
+5
| +0.1% | +$360 | 0.54% | 59 |
|
|
2022
Q3 | $509K | Buy |
7,160
+4
| +0.1% | +$284 | 0.57% | 50 |
|
|
2022
Q2 | $551K | Buy |
7,156
+5
| +0.1% | +$385 | 0.61% | 50 |
|
|
2022
Q1 | $522K | Buy |
7,151
+6
| +0.1% | +$438 | 0.48% | 59 |
|
|
2021
Q4 | $446K | Buy |
+7,145
| New | +$446K | 0.4% | 80 |
|